Who
Alan Bash
Interim CEO
Company insider
Files Form 4 as: Interim CEO, Legend Biotech; Chief Executive Officer, Checkmate Pharmaceuticals.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Mar 2022
- Last trade
- 14 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 18 Aug 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Code A | —4,908 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Code A | —4,908 at $0.00 | filing |
| 31 May 2022filed 31 May 2022 | Checkmate Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —575,000 | filing |
| 1 Mar 2022filed 2 Mar 2022 | Checkmate Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —575,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.